Co-Authors
This is a "connection" page, showing publications co-authored by Ravindra Ganesh and Dennis Bierle.
Connection Strength
2.525
-
Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211030826.
Score: 0.922
-
Reply to Puing et al. J Infect Dis. 2022 01 18; 225(2):353-355.
Score: 0.248
-
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
Score: 0.244
-
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
Score: 0.243
-
A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities. J Am Geriatr Soc. 2021 04; 69(4):868-873.
Score: 0.233
-
Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211019282.
Score: 0.230
-
Managing Patients in the COVID-19 Pandemic: A Virtual Multidisciplinary Approach. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5(1):118-126.
Score: 0.230
-
Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19. NPJ Digit Med. 2021 Aug 13; 4(1):123.
Score: 0.060
-
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261.
Score: 0.058
-
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618.
Score: 0.058